JP2013504075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013504075A5 JP2013504075A5 JP2012528396A JP2012528396A JP2013504075A5 JP 2013504075 A5 JP2013504075 A5 JP 2013504075A5 JP 2012528396 A JP2012528396 A JP 2012528396A JP 2012528396 A JP2012528396 A JP 2012528396A JP 2013504075 A5 JP2013504075 A5 JP 2013504075A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- fgf
- multiple sclerosis
- anosmin
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 8
- 208000016192 Demyelinating disease Diseases 0.000 claims 7
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims 7
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 7
- 102100023086 Anosmin-1 Human genes 0.000 claims 6
- 101710188941 Anosmin-1 Proteins 0.000 claims 6
- 239000013060 biological fluid Substances 0.000 claims 4
- 210000003169 central nervous system Anatomy 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 3
- 230000003902 lesion Effects 0.000 claims 3
- 201000006417 multiple sclerosis Diseases 0.000 claims 3
- 239000000523 sample Substances 0.000 claims 3
- 208000032194 Acute haemorrhagic leukoencephalitis Diseases 0.000 claims 2
- 206010012305 Demyelination Diseases 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 2
- 208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 230000008499 blood brain barrier function Effects 0.000 claims 2
- 210000001218 blood-brain barrier Anatomy 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 208000007118 chronic progressive multiple sclerosis Diseases 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 210000001428 peripheral nervous system Anatomy 0.000 claims 2
- 210000004885 white matter Anatomy 0.000 claims 2
- 201000011452 Adrenoleukodystrophy Diseases 0.000 claims 1
- 208000011403 Alexander disease Diseases 0.000 claims 1
- 208000022526 Canavan disease Diseases 0.000 claims 1
- 206010053684 Cerebrohepatorenal syndrome Diseases 0.000 claims 1
- 206010010252 Concentric sclerosis Diseases 0.000 claims 1
- 208000013279 Foix-Alajouanine syndrome Diseases 0.000 claims 1
- 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 claims 1
- 208000028226 Krabbe disease Diseases 0.000 claims 1
- 102000009030 Member 1 Subfamily D ATP Binding Cassette Transporter Human genes 0.000 claims 1
- 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 claims 1
- 208000003926 Myelitis Diseases 0.000 claims 1
- 206010042953 Systemic sclerosis Diseases 0.000 claims 1
- 201000004525 Zellweger Syndrome Diseases 0.000 claims 1
- 208000036813 Zellweger spectrum disease Diseases 0.000 claims 1
- 208000002552 acute disseminated encephalomyelitis Diseases 0.000 claims 1
- 208000018254 acute transverse myelitis Diseases 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000000877 corpus callosum Anatomy 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 210000004884 grey matter Anatomy 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 230000023105 myelination Effects 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 206010063401 primary progressive multiple sclerosis Diseases 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 201000008628 secondary progressive multiple sclerosis Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 208000009174 transverse myelitis Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP200930661 | 2009-09-07 | ||
| ES200930661A ES2356540B1 (es) | 2009-09-07 | 2009-09-07 | Método para predecir las características histopatológicas de las lesiones de un sujeto con una enfermedad desmielinizante del sistema nervioso central. |
| ESP201030090 | 2010-01-25 | ||
| ES201030090A ES2369099B1 (es) | 2010-01-25 | 2010-01-25 | La proteina Anosmina-1 como biomarcador para la clasificación histopatológica de lesiones de un sujeto con enfermedad desmielinizante del Sistema Nervioso Central. |
| PCT/ES2010/070584 WO2011045456A2 (es) | 2009-09-07 | 2010-09-07 | Nuevos biomarcadores de la histopatología de enfermedades desmielinizantes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013504075A JP2013504075A (ja) | 2013-02-04 |
| JP2013504075A5 true JP2013504075A5 (cg-RX-API-DMAC7.html) | 2013-10-24 |
Family
ID=43334531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012528396A Pending JP2013504075A (ja) | 2009-09-07 | 2010-09-07 | 疾患組織病理の新規バイオマーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120252688A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2477030A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2013504075A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010306515A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2773527A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011045456A2 (cg-RX-API-DMAC7.html) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2762602B1 (fr) * | 1997-04-28 | 1999-06-04 | Inst Nat Sante Rech Med | Moyens pour la detection precoce de pathologies auto-immunes inflammatoires |
-
2010
- 2010-09-07 JP JP2012528396A patent/JP2013504075A/ja active Pending
- 2010-09-07 EP EP10763733A patent/EP2477030A2/en not_active Withdrawn
- 2010-09-07 AU AU2010306515A patent/AU2010306515A1/en not_active Abandoned
- 2010-09-07 CA CA2773527A patent/CA2773527A1/en not_active Abandoned
- 2010-09-07 US US13/394,501 patent/US20120252688A1/en not_active Abandoned
- 2010-09-07 WO PCT/ES2010/070584 patent/WO2011045456A2/es not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fan et al. | Diagnosing sepsis–The role of laboratory medicine | |
| JP6941324B2 (ja) | 新規な肝硬変または肝線維症のマーカー | |
| Qiao et al. | Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection | |
| CN103403549B (zh) | 败血症的预后的预测方法 | |
| CA3052349C (en) | Proadm as marker indicating an adverse event | |
| KR20160029869A (ko) | 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커 | |
| WO2018029214A1 (en) | Histones and/or proadm as markers indicating an adverse event | |
| RU2764766C2 (ru) | Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции | |
| JP2014525593A (ja) | 心臓血管リスクを予測するための診断分析 | |
| Singh et al. | Proteomic approaches to decipher mechanisms underlying pathogenesis in multiple sclerosis patients | |
| JP2008509411A (ja) | 肝線維症の診断方法 | |
| RU2013158667A (ru) | Способ диагностики болезни гоше | |
| Snipsøyr et al. | Towards identification of novel putative biomarkers for infective endocarditis by serum proteomic analysis | |
| Kazamia et al. | Tissue and plasma proteomic profiling indicates AHSG as a potential biomarker for ascending thoracic aortic aneurysms | |
| JP2016511407A5 (cg-RX-API-DMAC7.html) | ||
| Liu et al. | The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C | |
| JP2008538812A5 (cg-RX-API-DMAC7.html) | ||
| US10557860B2 (en) | Circulating pulmonary hypertension biomarker | |
| JP6876301B2 (ja) | 肝細胞がん患者の再発リスク予測を補助する方法、装置、コンピュータプログラム製品及びキット | |
| CN107615071B (zh) | 用于包含乐伐替尼和依维莫司的联合疗法的生物标志 | |
| JP2013504075A5 (cg-RX-API-DMAC7.html) | ||
| CA2837522A1 (en) | Biomarkers for autoimmune liver diseases and uses thereof | |
| Zhang et al. | Unveiling promising sepsis biomarkers: a clinical perspective | |
| CN103698533A (zh) | Apo-A1蛋白在制备肺癌早期筛查或诊断用血清标记物的用途 | |
| Dumitrache et al. | Evaluating the Discriminative Performance of Noninvasive Biomarkers in Chronic Hepatitis B/C, Alcoholic Cirrhosis, and Nonalcoholic Cirrhosis: A Comparative Analysis |